A critical role for donor-derived IL-22 in cutaneous chronic GVHD

Simple item page
dc.contributor.authorGartlan, K.
dc.contributor.authorBommiasamy, H.
dc.contributor.authorPaz, K.
dc.contributor.authorWilkinson, A.
dc.contributor.authorOwen, M.
dc.contributor.authorReichenbach, D.
dc.contributor.authorBanovic, T.
dc.contributor.authorWehner, K.
dc.contributor.authorBuchanan, F.
dc.contributor.authorVarelias, A.
dc.contributor.authorKuns, R.
dc.contributor.authorChang, K.
dc.contributor.authorFedoriw, Y.
dc.contributor.authorShea, T.
dc.contributor.authorCoghill, J.
dc.contributor.authorZaiken, M.
dc.contributor.authorPlank, M.
dc.contributor.authorFoster, P.
dc.contributor.authorClouston, A.
dc.contributor.authorBlazar, B.
dc.contributor.authoret al.
dc.date.issued2018
dc.description.abstractGraft-versus-host disease (GVHD) is the major cause of nonrelapse morbidity and mortality after allogeneic stem cell transplantation (allo-SCT). Prevention and treatment of GVHD remain inadequate and commonly lead to end-organ dysfunction and opportunistic infection. The role of interleukin (IL)-17 and IL-22 in GVHD remains uncertain, due to an apparent lack of lineage fidelity and variable and contextually determined protective and pathogenic effects. We demonstrate that donor T cell-derived IL-22 significantly exacerbates cutaneous chronic GVHD and that IL-22 is produced by highly inflammatory donor CD4⁺ T cells posttransplantation. IL-22 and IL-17A derive from both independent and overlapping lineages, defined as T helper (Th)22 and IL-22⁺ Th17 cells. Donor Th22 and IL-22⁺ Th17 cells share a similar IL-6-dependent developmental pathway, and while Th22 cells arise independently of the IL-22⁺ Th17 lineage, IL-17 signaling to donor Th22 directly promotes their development in allo-SCT. Importantly, while both IL-22 and IL-17 mediate skin GVHD, Th17-induced chronic GVHD can be attenuated by IL-22 inhibition in preclinical systems. In the clinic, high levels of both IL-17A and IL-22 expression are present in the skin of patients with GVHD after allo-SCT. Together, these data demonstrate a key role for donor-derived IL-22 in patients with chronic skin GVHD and confirm parallel but symbiotic developmental pathways of Th22 and Th17 differentiation.
dc.description.statementofresponsibilityKate H. Gartlan, Hemamalini Bommiasamy, Katelyn Paz, Andrew N. Wilkinson, Mary Owen, Dawn K. Reichenbach, Tatjana Banovic, Kimberly Wehner, Faith Buchanan, Antiopi Varelias, Rachel D. Kuns, Karshing Chang, Yuri Fedoriw, Thomas Shea, James Coghill, Michael Zaiken, Maximilian W. Plank, Paul S. Foster, Andrew D. Clouston, Bruce R. Blazar, Jonathan S. Serody, Geoffrey R. Hill
dc.identifier.citationAmerican Journal of Transplantation, 2018; 18(4):810-820
dc.identifier.doi10.1111/ajt.14513
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttp://hdl.handle.net/2440/112052
dc.language.isoen
dc.publisherWiley
dc.relation.grantNHMRC
dc.rights© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons
dc.source.urihttps://doi.org/10.1111/ajt.14513
dc.subjectT cell biology
dc.subjectbasic (laboratory) research/science
dc.subjectbone marrow/hematopoietic stem cell transplantation
dc.subjectbronchiolitis obliterans (BOS)
dc.subjectcytokines/cytokine receptors
dc.subjectgraft-versus-host disease (GVHD)
dc.subjectimmunobiology
dc.subjectlymphocyte biology: differentiation/maturation
dc.titleA critical role for donor-derived IL-22 in cutaneous chronic GVHD
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications